Bausch Health Companies (BHC) Earnings (2009 - 2026)
Bausch Health Companies (BHC) earnings from Jun 30, 2009 to Mar 31, 2026. The TTM Bausch Health Companies (BHC) earnings is -$1.21B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Bausch Health Companies (BHC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2920.00% |
| 3 Years TTM | +50.13% |
| 5 Years TTM | +3.48% |
| 10 Years TTM | +4.75% |
Annual Earnings change of Bausch Health Companies (BHC)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$1.42B | -1006.37% |
| 2025 | $157M | -441.30% |
| 2024 | -$46M | -92.23% |
| 2023 | -$592M | +163.11% |
| 2022 | -$225M | -76.27% |
| 2021 | -$948M | +69.29% |
| 2020 | -$560M | -68.68% |
| 2019 | -$1.79B | -56.85% |
| 2018 | -$4.14B | -272.38% |
| 2017 | $2.40B | -199.83% |
| 2016 | -$2.41B | +736.69% |
| 2015 | -$288M | -132.70% |
| 2014 | $880M | -201.90% |
| 2013 | -$864M | +644.48% |
| 2012 | -$116M | -172.70% |
| 2011 | $160M | -56.48% |
| 2010 | $367M | -9.82% |
| 2009 | $407M | +103.40% |
| 2008 | $200M | N/A |
Comparison Bausch Health Companies (BHC) five years earnings CAGR with competitors
Bausch Health Companies (BHC) five years earnings CAGR is 3.48%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +2763.29% |
| INCR | INC Research Holdings Inc | 64.08% | +1740.59% |
| TLRY | Tilray Brands Inc | 57.78% | +1559.37% |
| PRGO | Perrigo Company plc | 51.08% | +1367.15% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +892.71% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +715.14% |
| UTHR | United Therapeutics Corp | 26.00% | +646.71% |
| SBFM | Sunshine Biopharma Inc | 23.97% | +588.36% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +522.11% |
| AYTU | Aytu BioPharma Inc | 21.24% | +510.16% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | +396.54% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | +386.31% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | +239.71% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | +207.61% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | +199.74% |
| ZTS | Zoetis Inc - Class A | 8.54% | +145.18% |
| KMDA | Kamada Ltd | 6.87% | +97.32% |
| AQST | Aquestive Therapeutics Inc | 5.03% | +44.37% |
| PRFX | PRF Technologies Ltd | 4.38% | +25.82% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | +7.72% |
| CPHI | China Pharma Holdings Inc | 3.58% | +2.86% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -15.73% |